Skip to main content

National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.

Publication ,  Journal Article
Arnold, LE; Abikoff, HB; Cantwell, DP; Conners, CK; Elliott, G; Greenhill, LL; Hechtman, L; Hinshaw, SP; Hoza, B; Jensen, PS; Kraemer, HC ...
Published in: Arch Gen Psychiatry
September 1997

The Collaborative Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (ADHD), the MTA, is the first child multisite cooperative agreement treatment study of children conducted by the National Institute of Mental Health, Rockville, Md. It examines the long-term effectiveness of medication vs behavioral treatment vs both for treatment of ADHD and compares state-of-the-art treatment with routine community care. In a parallel-groups design, 576 children (age, 7-9 years) with ADHD (96 at each site) are thoroughly assessed and randomized to 4 conditions: (1) medication alone, (2) psychosocial treatment alone, (3) the combination of both, (4) or community comparison. The first 3 groups are treated for 14 months and all are reassessed periodically for 24 months. Designers met the following challenges: framing clinically relevant primary questions; defining the target population; choice, intensity, and integration and combination of treatments for fair comparisons; combining scientific controls and standardization with clinical flexibility; and implementing a controlled clinical trial in a nonclinical setting (school) controlled by others. Innovative solutions included extensive decision algorithms and manualized adaptations of treatments to specific needs.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Arch Gen Psychiatry

DOI

ISSN

0003-990X

Publication Date

September 1997

Volume

54

Issue

9

Start / End Page

865 / 870

Location

United States

Related Subject Headings

  • United States
  • Research Design
  • Psychiatry
  • Pemoline
  • Patient Selection
  • National Institute of Mental Health (U.S.)
  • Methylphenidate
  • Male
  • Imipramine
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arnold, L. E., Abikoff, H. B., Cantwell, D. P., Conners, C. K., Elliott, G., Greenhill, L. L., … Wells, K. C. (1997). National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry, 54(9), 865–870. https://doi.org/10.1001/archpsyc.1997.01830210113015
Arnold, L. E., H. B. Abikoff, D. P. Cantwell, C. K. Conners, G. Elliott, L. L. Greenhill, L. Hechtman, et al. “National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.Arch Gen Psychiatry 54, no. 9 (September 1997): 865–70. https://doi.org/10.1001/archpsyc.1997.01830210113015.
Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, et al. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry. 1997 Sep;54(9):865–70.
Arnold, L. E., et al. “National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.Arch Gen Psychiatry, vol. 54, no. 9, Sept. 1997, pp. 865–70. Pubmed, doi:10.1001/archpsyc.1997.01830210113015.
Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott G, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, Kraemer HC, March JS, Newcorn JH, Pelham WE, Richters JE, Schiller E, Severe JB, Swanson JM, Vereen D, Wells KC. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry. 1997 Sep;54(9):865–870.

Published In

Arch Gen Psychiatry

DOI

ISSN

0003-990X

Publication Date

September 1997

Volume

54

Issue

9

Start / End Page

865 / 870

Location

United States

Related Subject Headings

  • United States
  • Research Design
  • Psychiatry
  • Pemoline
  • Patient Selection
  • National Institute of Mental Health (U.S.)
  • Methylphenidate
  • Male
  • Imipramine
  • Humans